Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06043674
Title A Phase 2 Study of Glofitamab as Monotherapy or in Combination With Polatuzumab Vedotin or Atezolizumab in Richter's Transformation
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Matthew S. Davids, MD
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.